Cyclops®

  • Convenient
  • Reliable
  • Easy-to-use
  • Easy-to-carry
  • Hygienic
  • Less Cough

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS

Month: September 2024

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS

| Posted on |

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS

Fagron and PureIMS have joined forces to make CYCLOPS® dry powder inhaler available nationwide in the Netherlands. The two Dutch pharmaceutical companies recently signed an agreement, granting Fagron the exclusive rights to organize the national distribution of PureIMS’s compounded preparations, such as an inhaled antibiotic for the treatment of pulmonary Pseudomonas aeruginosa infections caused by […]

International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®

| Posted on |

International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®

Please check out our latest poster (#708) presenting clinical study results of a head-to-head comparison between Levodopa Cyclops® and Inbrija®. Highlights are: Levodopa Cyclops® is safe and very well tolerated (no cough). Levodopa absorption from Cyclops® is comparable to Inbrija®, thereby, fulfilling the bioequivalence criteria. Results enable abbreviated registration routes with a limited – PK-only […]

Contact Us

Ceintuurbaan Noord 152
9301 NZ Roden
The Netherlands
T: +31 (0)50 – 2053 325
F: +31 (0)50 – 2053 326
E: info@pureims.com

Social media

Linkedin-in Youtube

Inspiration by Patients

CALL US NOW
© 2024 pureims